Stroke RSS Page 6

Filtered By:
Source: Heart, Lung and Circulation

This page shows you your search results in order of date. This is page number 6.

Order by Relevance | Date

Total 240 results found since Jan 2013.

Letter to the Editor regarding: Critical considerations for stroke management during COVID-19 pandemic by Inglis et al., Heart Lung Circ. 2020;29(9): 1263 –1267.
Source: Heart, Lung and Circulation - October 9, 2020 Category: Cardiology Authors: Skye Coote, Dominique A. Cadilhac, Elizabeth O ’Brien, Sandy Middleton, Acute Stroke Nurses Education Network (ASNEN) Steering Committee Tags: Letter to the Editor Source Type: research

Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage
Subarachnoid haemorrhage (SAH) accounts for 5% –10% of strokes and its prognosis may be influenced by different complications, including delayed cerebral ischaemia (DCI). The pathophysiology of DCI is complex and still unknown. Many different mechanisms may contribute to the occurrence of DCI. Arterial stiffness (AS), a well-known risk factor for cardiovascular events, also associated to the development and rupture of cerebral aneurysms, may represent a novel contributing risk factor. The aim of our study was to investigate a possible link between AS and DCI after SAH.
Source: Heart, Lung and Circulation - August 16, 2020 Category: Cardiology Authors: Maurizio Acampa, Marianna Bongiorno, Pietro Enea Lazzerini, Cecilia Catania, Carlo Domenichelli, Francesca Guideri, Rossana Tassi, Alessandra Cartocci, Giuseppe Martini Tags: Original Article Source Type: research

Anticoagulant Initiation During Hospital Admissions for Atrial Fibrillation in South-East Queensland, Australia
Anticoagulation reduces stroke risk in patients with atrial fibrillation (AF) but under-prescribing in eligible patients has been commonly reported. Introduction of the direct acting oral anticoagulants (DOACs) was considered to potentially improve prescribing due to increased anticoagulant options. At the time of release to the Australian market, there were limited studies investigating anticoagulant usage during hospitalisations for AF. Therefore, the aim of this study was to investigate prescribing of oral anticoagulants during hospitalisation admissions for AF during the time of DOAC introduction to the Australian market.
Source: Heart, Lung and Circulation - March 31, 2020 Category: Cardiology Authors: Iniya Rathinam, Shailendra Anoopkumar-Dukie, Tony Badrick, Trudy Teasdale, Nijole Bernaitis Tags: Original Article Source Type: research

Cardiac Rehabilitation and Secondary Prevention Roundtable: Australian Implementation and Research Priorities
Cardiovascular disease (CVD), including coronary heart disease (CHD) and stroke, is the leading cause of death and disease burden globally [1]. CVD resulted in>1.1 million hospitalisations in 2015-16, and incurs the highest level of health care sector expenditure in Australia (11-12% of total health expenditure) [2]. CHD accounts for the greatest single disease morbidity (>500,000 bed-days annually) and nearly one fifth of all deaths with a total cost of $1.14 billion annually [2]. Over 65,000 Australians experience an acute coronary event (heart attack or unstable angina) each year [3], and, importantly, around a third of...
Source: Heart, Lung and Circulation - February 28, 2020 Category: Cardiology Authors: Julie Redfern, Gemma Figtree, Clara Chow, Garry Jennings, Tom Briffa, Robyn Gallagher, Rachelle Foreman, on behalf of Roundtable Attendees Tags: Editorial Source Type: research

Outcomes of Asian-Americans Implanted With Left Ventricular Assist Devices: An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Analysis
Studies have indicated differences between Asians and Whites in their propensity for stroke, coronary artery disease, heart failure, bleeding and thrombosis. We investigated whether Asian-Americans on durable left ventricular assist devices (LVADs) exhibit differential morbidity and mortality when compared to Whites.
Source: Heart, Lung and Circulation - December 8, 2019 Category: Cardiology Authors: Iosif Taleb, James Wever-Pinzon, Wenyan Wang, Antigone Koliopoulou, Elizabeth Dranow, Tao Yu, Lixue Yin, Stephen H. McKellar, Josef Stehlik, James C. Fang, Omar Wever-Pinzon, Craig H. Selzman, Stavros G. Drakos Tags: Original Article Source Type: research

Adherence to Cardiac Medications in Patients With Atrial Fibrillation: A Pilot Study
This study aimed to explore medication adherence in patients with AF, and explore associations with health literacy, cognition, or AF knowledge.
Source: Heart, Lung and Circulation - December 4, 2019 Category: Cardiology Authors: Adrienne Pacleb, Nicole Lowres, Sue Randall, Lis Neubeck, Robyn Gallagher Tags: Original Article Source Type: research

Quality of Warfarin Anticoagulation in Indigenous and Non-Indigenous Australians With Atrial Fibrillation
Studies have shown that suboptimal anticoagulation quality, as measured by time in therapeutic range (TTR), affects a significant percentage of patients with atrial fibrillation (AF). However, TTR has not been previously characterised in Indigenous Australians who experience a greater burden of AF and stroke.
Source: Heart, Lung and Circulation - November 27, 2019 Category: Cardiology Authors: Mau T. Nguyen, Celine Gallagher, Bradley M. Pitman, Mehrdad Emami, Kadhim Kadhim, Jeroen M. Hendriks, Melissa E. Middeldorp, Kurt C. Roberts-Thomson, Rajiv Mahajan, Dennis H. Lau, Prashanthan Sanders, Christopher X. Wong Tags: Original Article Source Type: research

Plasma Level of Interferon- γ Predicts the Prognosis in Patients With New-Onset Atrial Fibrillation
Patients with atrial fibrillation are at increased risk of stroke and mortality. It is not clear if inflammatory biomarkers are associated with stroke and mortality in patients with atrial fibrillation. We aimed to evaluate the predictive value of three inflammatory biomarkers (interleukin [IL]-9, IL-10, and interferon [IFN]- γ) for stroke and mortality in atrial fibrillation.
Source: Heart, Lung and Circulation - November 21, 2019 Category: Cardiology Authors: Jiaqi Huang, Ying Xiang, Huan Zhang, Na Wu, Xinghua Chen, Long Wu, Bin Xu, Chengying Li, Zhihui Zhang, Shifei Tong, Li Zhong, Yafei Li Tags: Original Article Source Type: research

Is Atrial Fibrillation a Stroke Risk Factor or Risk Marker? An Appraisal Using the Bradford Hill Framework for Causality
Atrial fibrillation (AF) is strongly associated with stroke risk but association on its own does not necessarily imply causality. Is AF a cause (risk factor) of stroke? Would treatment that reduces AF burden also reduce the burden of stroke? Or, perhaps, AF is a risk marker associated with a vascular syndrome in which there is co-existing atrial structural and electrical remodelling that results in the clinical manifestation of AF and the risk of stroke in parallel. A number of recent studies appear to detach AF as a direct cause of stroke.
Source: Heart, Lung and Circulation - August 13, 2019 Category: Cardiology Authors: V. Malik, A.N. Ganesan, J.B. Selvanayagam, D.P. Chew, A.D. McGavigan Tags: Review Source Type: research

Predicted Impact of Recent Patent Foramen Ovale Closure Trials on Management of Cryptogenic Stroke
Background: The indication for percutaneous closure of patent foramen ovale (PFO) has recently changed, following evidence that closure is superior to medical treatment alone in preventing recurrent stroke in cryptogenic stroke patients aged ≤60 years. We aimed to determine the impact of updated criteria on the management of stroke or transient ischemic attack (TIA) at our institution.
Source: Heart, Lung and Circulation - June 23, 2019 Category: Cardiology Authors: P. Trevella, L. Sanders, D. Jin, J. Gutman, MacA. Isaac, S. Palmer Tags: 667 Source Type: research

Contemporary Trends in Stroke Complicating Cardiac Catheterisation
Background: Stroke remains an important complication of diagnostic cardiac catheterization and percutaneous coronary intervention and is associated with high rates of in-hospital mortality.
Source: Heart, Lung and Circulation - June 23, 2019 Category: Cardiology Authors: N. Whitehead, T. Williams, S. Brienesse, D. Ferriera, N. Murray, K. Inder, S. Beautement, N. Spratt, A. Boyle, N. Collins Tags: 597 Source Type: research

Atrial Fibrillation and Indigenous Australians: A way Forward for Timely and Effective Screening and Treatment
Background: The leading cause of death for Indigenous Australians is cardiovascular disease, including stroke. Atrial Fibrillation (AF) increases stroke risk 5 –7 fold. Early detection and treatment of AF in Caucasians has proven feasible. Aim: To estimate AF prevalence in community settings and examine feasibility of using a handheld single-lead ECG device (iECG) for Indigenous Australians.
Source: Heart, Lung and Circulation - June 23, 2019 Category: Cardiology Authors: K. Gwynne, J. Gwynn, H. Finlayson, S. Hamilton, M. Lawrence, R. MacNiven, L. Neubeck, B. Rambaldini, R. Rodrigues, K. Taylor, S. Thompson, B. Freedman Tags: 514 Source Type: research

Implementing a Primary PCI Urgent Transfer Process as First Line Management of STEMI at a Non-PCI Hospital in a Large Regional Area
Introduction: Primary PCI (pPCI) has been demonstrated to be superior to fibrinolysis therapy in reducing mortality, recurrent MI and stroke but benefits are lost if the delay to PCI is>121 mins (1). ESC recommends pPCI as the preferred reperfusion strategy provided PCI can be performed within 120mins from STEMI diagnosis. (2). CSANZ guidelines recommend PCI if a “Door in-Door Out time” (DI-DO) of ≤30mins can be achieved. Wollongong Hospital (WH) is the PCI-capable centre for the ISLHD. Bulli District Hospital (BDH) and Shellharbour Hospital (SHH) are a short drive to WH (18 and 34 minutes respectively).
Source: Heart, Lung and Circulation - June 23, 2019 Category: Cardiology Authors: M. Aquilina Tags: 488 Source Type: research

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16